

![]() |
Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers |
|
Collaboration | With : Marizzoni, Moira / Frisoni, Giovanni | |
Published in | Journal of Alzheimer's disease. 2019, vol. 69, no. 1, p. 3-14 | |
Abstract | Early Alzheimer's disease (AD) detection using cerebrospinal fluid (CSF) biomarkers has been recommended as enrichment strategy for trials involving mild cognitive impairment (MCI) patients. | |
Keywords | Alzheimer's disease — Biomarkers — Clinical trial — Magnetic resonance imaging — Mild cognitive impairment — Precision medicine | |
Identifiers | DOI: 10.3233/JAD-180152 PMID: 29914031 | |
Full text | ||
Structures | ||
Research group | Troubles de mémoire et maladie d'Alzeimer (935) | |
Citation (ISO format) | THE PHARMACOG CONSORTIUM. Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers. In: Journal of Alzheimer's Disease, 2019, vol. 69, n° 1, p. 3-14. doi: 10.3233/JAD-180152 https://archive-ouverte.unige.ch/unige:116115 |